XML 38 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Schedule of Stock Option Activity

The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the three months ended March 31, 2025:

 

 

 

Number of Options Outstanding

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Life

 

Aggregate Intrinsic Value(1)

 

 

 

(in thousands)

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2024(2)

 

 

8,438

 

 

$

12.93

 

 

 

 

 

 

Granted

 

 

 

 

$

 

 

 

 

 

 

Exercised

 

 

(3

)

 

$

2.56

 

 

 

 

 

 

Forfeited or expired(3)

 

 

(231

)

 

$

9.99

 

 

 

 

 

 

Outstanding as of March 31, 2025(2)

 

 

8,204

 

 

$

13.01

 

 

4.0 years

 

$

2

 

Exercisable as of March 31, 2025(4)

 

 

8,079

 

 

$

13.06

 

 

4.0 years

 

$

2

 

Vested and expected to vest as of March 31, 2025(5)

 

 

8,204

 

 

$

13.01

 

 

4.0 years

 

$

2

 

 

 

(1)
The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.
(2)
Includes 3,620 and 3,558 performance condition stock options as of March 31, 2025 and December 31, 2024, respectively.
(3)
Includes 62 performance condition stock options.
(4)
Includes 3,558 performance condition stock options.
(5)
Includes 3,558 performance condition stock options.
Schedule of Stock-based Compensation Expense

The following table provides information about stock-based compensation expense by award type:

 

 

Three Months Ended

 

 

March 31,
2025

 

 

March 31,
2024

 

Stock options

 

$

334

 

 

$

572

 

Restricted stock units

 

 

1,026

 

 

 

807

 

Employee stock purchase plan

 

 

383

 

 

 

156

 

Total stock-based compensation expense

 

$

1,743

 

 

$

1,535

 

 

The following table provides information about stock-based compensation expense by financial statement line item:

 

 

Three Months Ended

 

 

March 31,
2025

 

 

March 31,
2024

 

Cost of revenue (exclusive of depreciation and amortization)

 

$

 

 

$

(1

)

Sales and marketing

 

 

264

 

 

 

159

 

Research and development

 

 

318

 

 

 

532

 

General and administrative

 

 

1,161

 

 

 

845

 

Total stock-based compensation expense

 

$

1,743

 

 

$

1,535

 

Schedule of Restricted Stock Unit Activity

The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the three months ended March 31, 2025:

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value Per Share

 

 

 

(in thousands)

 

 

 

 

Outstanding and nonvested as of December 31, 2024(1)

 

 

1,902

 

 

$

4.94

 

Granted(2)

 

 

817

 

 

$

3.95

 

Vested

 

 

(232

)

 

$

6.29

 

Forfeited(3)

 

 

(425

)

 

$

5.55

 

Outstanding and nonvested as of March 31, 2025(1)

 

 

2,062

 

 

$

4.28

 

 

(1)
Includes 323 and 248 performance condition RSUs as of March 31, 2025 and December 31, 2024, respectively.
(2)
Includes 323 performance condition RSUs.
(3)
Includes 248 performance condition RSUs.